X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8610) 8610
Book Review (972) 972
Publication (243) 243
Conference Proceeding (21) 21
Magazine Article (10) 10
Book Chapter (6) 6
Book / eBook (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8100) 8100
humans (8005) 8005
antineoplastic combined chemotherapy protocols - therapeutic use (5063) 5063
female (4853) 4853
male (4844) 4844
vinblastine - administration & dosage (4263) 4263
middle aged (4024) 4024
adult (3791) 3791
oncology (3505) 3505
aged (3284) 3284
vinblastine - therapeutic use (2818) 2818
vinblastine - analogs & derivatives (2474) 2474
chemotherapy (2269) 2269
cisplatin - administration & dosage (2253) 2253
vinblastine (1942) 1942
treatment outcome (1657) 1657
antineoplastic combined chemotherapy protocols - adverse effects (1573) 1573
doxorubicin - administration & dosage (1467) 1467
lung neoplasms - drug therapy (1406) 1406
combined modality therapy (1369) 1369
vinblastine - adverse effects (1356) 1356
bleomycin - administration & dosage (1351) 1351
cancer (1317) 1317
hodgkin disease - drug therapy (1279) 1279
neoplasm staging (1247) 1247
cisplatin (1228) 1228
adolescent (1203) 1203
carcinoma, non-small-cell lung - drug therapy (1065) 1065
antineoplastic agents - therapeutic use (1028) 1028
prognosis (981) 981
vinorelbine (971) 971
survival rate (917) 917
abridged index medicus (865) 865
deoxycytidine - analogs & derivatives (848) 848
drug administration schedule (843) 843
survival analysis (801) 801
antineoplastic combined chemotherapy protocols - administration & dosage (796) 796
animals (793) 793
breast neoplasms - drug therapy (788) 788
methotrexate - administration & dosage (764) 764
aged, 80 and over (743) 743
follow-up studies (741) 741
vincristine - administration & dosage (717) 717
disease-free survival (713) 713
doxorubicin (689) 689
retrospective studies (686) 686
deoxycytidine - administration & dosage (679) 679
dacarbazine - administration & dosage (676) 676
urinary bladder neoplasms - drug therapy (672) 672
therapy (651) 651
pharmacology & pharmacy (635) 635
cyclophosphamide - administration & dosage (633) 633
etoposide - administration & dosage (625) 625
remission induction (618) 618
cisplatin - therapeutic use (602) 602
prednisone - administration & dosage (600) 600
doxorubicin - therapeutic use (592) 592
neoplasm metastasis (589) 589
lung neoplasms - pathology (582) 582
bleomycin - therapeutic use (573) 573
procarbazine - administration & dosage (561) 561
child (559) 559
methotrexate (557) 557
hodgkin disease - radiotherapy (537) 537
trial (537) 537
drug therapy, combination (535) 535
survival (525) 525
time factors (518) 518
hodgkin disease - pathology (511) 511
testicular neoplasms - drug therapy (509) 509
antineoplastic agents, phytogenic - therapeutic use (508) 508
radiotherapy (503) 503
carcinoma, transitional cell - drug therapy (499) 499
vincristine - therapeutic use (498) 498
paclitaxel - administration & dosage (495) 495
cisplatin - adverse effects (494) 494
chemotherapy, adjuvant (486) 486
cyclophosphamide - therapeutic use (486) 486
carcinoma (482) 482
care and treatment (472) 472
hematology (464) 464
paclitaxel (464) 464
gemcitabine (460) 460
carcinoma, non-small-cell lung - pathology (455) 455
vinblastine - pharmacology (447) 447
dose-response relationship, drug (430) 430
clinical trials as topic (426) 426
mice (423) 423
combination chemotherapy (417) 417
carboplatin - administration & dosage (415) 415
breast neoplasms - pathology (412) 412
urinary bladder neoplasms - pathology (410) 410
prospective studies (399) 399
methotrexate - therapeutic use (398) 398
prednisone - therapeutic use (396) 396
antineoplastic agents, phytogenic - administration & dosage (392) 392
combination (380) 380
bleomycin (371) 371
urology & nephrology (371) 371
bleomycin - adverse effects (366) 366
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7202) 7202
Japanese (376) 376
French (302) 302
German (239) 239
Russian (116) 116
Chinese (89) 89
Italian (85) 85
Spanish (79) 79
Polish (62) 62
Hungarian (18) 18
Czech (12) 12
Hebrew (8) 8
Dutch (7) 7
Bulgarian (4) 4
Portuguese (4) 4
Romanian (4) 4
Serbian (4) 4
Danish (3) 3
Finnish (3) 3
Lithuanian (2) 2
Afrikaans (1) 1
Croatian (1) 1
Icelandic (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 08/2016, Volume 34, Issue 23, pp. 2690 - 2697
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 3, pp. 203 - 212
BEACOPP combination chemotherapy was compared with ABVD chemotherapy in advanced Hodgkin's disease. BEACOPP therapy was associated with higher initial rates of... 
CELL TRANSPLANT | MEDICINE, GENERAL & INTERNAL | VINORELBINE | MOPP | DISEASE | REGIMEN | IFOSFAMIDE | CHEMOTHERAPY | STANDARD | HYBRID | FERTILITY | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Lymphomas | Hodgkin's disease | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 11, pp. 1015 - 1026
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2011, Volume 152, Issue 5, pp. 551 - 560
Journal Article
Annals of Oncology, ISSN 0923-7534, 2014, Volume 25, Issue 8, pp. 1622 - 1628
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 06/2016, Volume 374, Issue 25, pp. 2419 - 2429
Journal Article
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 07/2012, Volume 23, Issue 7, pp. 1818 - 1825
In the HD14 trial, 2x BEACOPP(escalated) + 2x ABVD (2 + 2) has improved the primary outcome. Compared with 4x ABVD, this benefit might be compromised by more... 
Chemotherapy | GnRH analogues | Fertility | Ovarian reserve | Hodgkin lymphoma | fertility | ovarian reserve | ANTI-MULLERIAN HORMONE | chemotherapy | CANCER | PRESERVATION | WOMEN | THERAPY | ONCOLOGY | CLINICAL-TRIALS | DISEASE | ORAL-CONTRACEPTIVES | OVARIAN-FUNCTION | Doxorubicin - therapeutic use | Multivariate Analysis | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Gonadotropin-Releasing Hormone - analogs & derivatives | Cyclophosphamide - therapeutic use | Young Adult | Bleomycin - therapeutic use | Menopause - drug effects | Vinblastine - adverse effects | Fertility - drug effects | Follicle Stimulating Hormone - blood | Hodgkin Disease - drug therapy | Adult | Female | Ovary - drug effects | Gonadotropin-Releasing Hormone - therapeutic use | Menstrual Cycle - drug effects | Anti-Mullerian Hormone - blood | Etoposide - adverse effects | Prednisone - adverse effects | Survivors | Etoposide - therapeutic use | Logistic Models | Bleomycin - adverse effects | Randomized Controlled Trials as Topic | Pregnancy | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Ovary - physiopathology | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 05/2013, Volume 121, Issue 18, pp. 3547 - 3553
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2012, Volume 366, Issue 5, pp. 399 - 408
In patients with limited-stage Hodgkin's disease, ABVD chemotherapy alone resulted in a higher rate of long-term (12-year) survival than either radiation... 
CLINICAL-PRACTICE GUIDELINES | MEDICINE, GENERAL & INTERNAL | INTERGROUP TRIAL | RANDOMIZED-TRIALS | DISEASE | DOXORUBICIN | VINBLASTINE | BLEOMYCIN | FIELD RADIOTHERAPY | CHEMOTHERAPY | COOPERATIVE-ONCOLOGY-GROUP | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Follow-Up Studies | Dacarbazine - therapeutic use | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Neoplasms, Second Primary - mortality | Radiotherapy - adverse effects | Vinblastine - therapeutic use | Cause of Death | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Treatment Outcome | Combined Modality Therapy | Bleomycin - adverse effects | Hodgkin Disease - complications | Heart Diseases - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Neoplasm Staging | Doxorubicin - adverse effects | Drugs | Usage | Care and treatment | Vinblastine | Patient outcomes | Product/Service Evaluations | Radiotherapy | Doxorubicin | Dacarbazine | Bleomycin | Dosage and administration | Drug therapy, Combination | Drug therapy | Hodgkin's disease | Medical research | Clinical trials | Radiation therapy | Lymphoma | Survival | Patients | Chemotherapy | Lymphomas | Index Medicus | Abridged Index Medicus
Journal Article